Neuroleptic malignant syndrome and severe thrombocytopenia: Case report and literature review

Annals of Clinical Psychiatry

Volumn 12, Issue 1, 2000, Pages 51-54

  Ghani, Shareh O ^a,c   Ahmed, Waqas ^b   Marco, Luis A ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Neuroleptic malignant syndrome; Neuroleptics; Thrombocytopenia

Indexed keywords

BENZATROPINE; DANTROLENE; HALOPERIDOL; HALOPERIDOL DECANOATE; NEUROLEPTIC AGENT; PROPRANOLOL; VALPROIC ACID;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; DISEASE ASSOCIATION; FOCAL EPILEPSY; HUMAN; HYPERPYREXIA; HYPERTENSION; HYPERTHERMIA; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; RIGIDITY; SCHIZOPHRENIA; SYMPTOM; TACHYCARDIA; TACHYPNEA; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; ANTIPSYCHOTIC AGENTS; DRUG THERAPY, COMBINATION; HALOPERIDOL; HUMANS; MALE; NEUROLEPTIC MALIGNANT SYNDROME; SCHIZOPHRENIA; THROMBOCYTOPENIA; VALPROIC ACID;

EID: 0034050779     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009079127829     Document Type: Article

References (17)

1. Rosebush P, Stewart T: A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry 1989; 146:717-725
2. Swett CC: Adverse reactions to chlorpromazine in medical patients: A report from the Boston Collaborative Drug Surveillance Program. Curr Ther Res 1975; 18:199-206
3. McFarland RB: Fatal drug reaction associated with prochlorperazine (compazine). Report of a case characterized by jaundice, thrombocytopenia, and agranulocytosis. Am J Clin Pathol 1963; 50:284.
4. Storrie MC, Scher M, McGuire J, Bokan J: Thrombocytopenia with absence of leukopenia associated with the use of neuroleptics. J Clin Psychiatry 1978; 72:779-782
5. Holt RJ: Neuroleptic drug-induced changes in platelet levels: J Clin Psychopharm 1984; 4:130-132
6. Balon R, Berchou R: Hematologic side effects of psychotropic drugs. Psychosomatics 1986; 217:119-127
7. Ray JG: Neuroleptic malignant syndrome associated with thrombocytopenia. J Intern Med 1997; 241:245-247
8. Delay J, Deniker P: Drug induced extrapyramidal syndromes. In: Vinken RJ, Bruyn GW, eds. Handbook of Clinical Neurology: Disease of the Basal Ganglia, Vol. 6, New York, Elsevier North-Holland 1968; 248-266
9. Lenler-Peterson P, Hausen BD, Hasselstorm L: A rapidly progressing lethal case of neuroleptic malignant syndrome. Intensive Care Med 1990; 16:267-268
10. Yao JK, Yassai P, Van Kammen DP: Increased turnover of platelet phosphotidyl inositol in schizophrenia, Prostaglandins Leukotrienes Essential Fatty Acids 1992; 46:38-46
11. Kaiya H: Second messenger imbalance hypothesis of schizophrenia. Prostaglandins Leukotrienes Essential Fatty Acids 1992; 46:33-38
12. Pletscher A: Liberation of catecholamines from blood platelets. Br J Pharmacol 1981 (February)
13. Essali MA, Das I: Regulation of the platelet phosphoinositide system by antipsychotic drugs: A specific neuroleptic action. Schizophrenia Res 1990; 3:36-37
14. Kaiya H, et al.: Accumulation of diacylglycerol in platelet phosphotidylinositide turnover in schizophrenia: A biological marker of good prognosis? Biol Psychiatry 1989; 26:669-676
15. Loiseau P: Sodium valproate, platelet dysfunction, and bleeding. Epilepsia 1981; 22:141-146
16. Tohen M, et al.: Blood dyscrasia with carbamazepine and valproate: A pharmacoepidemiological study of 2,228 patients at risk. Am J Psychiatry 1995; 152:413-418
17. Vadney V: Unusual clusters of valproate-associated thrombocytopenia. J Epilepsy 1992; 5:186-190